Rich page
Symposium on Interventional Radiology in Gynaecology
Interventional radiology in gynecology: minimally invasive innovations to preserve health and fertility Interventional radiology is playing an increasingly important role in the management of gynecological conditions. Thanks to image-guided minimally invasive techniques, it provides alternatives or complements to conventional treatments, with potential benefits including organ preservation, reduced complications and improved patients’ quality of life.This symposium will provide a multidisciplinary overview of the latest advances in interventional radiology applied to gynecology. Gynecologists, interventional radiologists and specialists involved in the management of pelvic pathologies will come together to discuss current indications, clinical outcomes and future perspectives of these approaches.Therapeutic innovations at the heart of gynecological careTargeted embolization: a conservative approach for uterine conditionsArterial embolization allows precise targeting of the blood supply of certain gynecological lesions, offering an alternative or complement to conventional treatments while preserving the uterus.This session will address in particular:Uterine fibroids (fibromyomas): indications, clinical outcomes and the role of embolization within today’s therapeutic options.Pelvic adenomyosis: new perspectives for managing a condition often responsible for chronic pain and menstrual disorders.Thermal ablation: new minimally invasive strategies for deep endometriosisThermal ablation opens up new perspectives in the management of certain deep endometriosis lesions through a targeted approach that limits the impact on surrounding tissues. This session will present the indications, available outcomes and the role of this technique within a personalized therapeutic strategy.Pelvic vascular conditions: diagnosing and treating differentlySome chronic pelvic pain conditions may be related to vascular abnormalities. Experts will present recent advances in:Pelvic varices embolization: a targeted approach to treating pelvic congestion syndrome in selected patients.Management of varicoceles: with particular focus on indications and outcomes.Restoring fertility: the potential of selective tubal recanalizationIn certain cases of proximal tubal obstruction, selective tubal recanalization is a minimally invasive approach that may restore tubal patency. This session will explore its role within infertility care pathways and its integration into individualized patient management.A comprehensive reflection on interventional radiology in gynecologyCross-cutting challenges: responsible practice of interventional radiology in gynecologyBeyond technical innovations, the development of these approaches raises essential questions:What ethical challenges will accompany the evolution of these practices?How can economic considerations be integrated into therapeutic decision-making?How can radiation protection for patients and healthcare professionals be optimized?A comprehensive reflection is essential to ensure innovative, responsible and patient-centered medicine.A symposium to strengthen collaboration between specialistsThis symposium is aimed at gynecologists wishing to deepen their knowledge of available interventional techniques in gynecology and better identify situations in which these approaches can be offered to their patients.It provides an opportunity to exchange with specialists in interventional radiology and gynecology through clinical cases, practical experiences and discussions on future developments.Practical informationDate: Saturday, 21 November 2026Time: 08:00 AM to 03:00 PMLocation: Museum of Medicine, Erasme Campus – Place Facultaire. Route de Lennik 808, 1070 Anderlecht. AccessTarget audience: gynecologists, interventional radiologists and specialists involved in the management of pelvic pathologiesAccredited symposium organized under the direction of Dr Salvatore Murgo and Dr Arnaud Bourguignon.Free registration required (registration deadline: 14/11/2026)Contact: Interventional Radiology Angiography Coordination, coordination [dot] RI [at] hubruxelles [dot] be Registration
Rich page
Symposium on Pediatric Epilepsy Surgery
On November 8, 2024, the Brussels University Hospital(H.U.B.) will host an international symposium dedicated to pediatric epilepsy neurosurgery. This event will bring together national and international experts to discuss the latest advancements and explore future perspectives in this highly specialized field Program and ThemesThe symposium will focus on several major themes aimed at improving the management of epileptic patients, particularly children resistant to medication. Topics to be covered include:Utilization of SEEG (Stereo-electroencephalography) and LITT (Laser Interstitial Thermal Therapy): These advanced techniques are crucial for pediatric patients whose epilepsy does not respond to traditional pharmaceutical treatments. SEEG provides a detailed analysis of brain activity to precisely locate epileptogenic zones, while LITT offers a minimally invasive method to treat these areas without resorting to traditional open surgery.Analysis of Neural Connectivity: This innovative method aims to predict the absence of postoperative seizures, allowing for more precise surgical planning and optimized outcomes for patients.New Surgical Approaches: The symposium will introduce a novel concept of proposing resective surgery for non-refractory focal epileptic children. The goal is to minimize the impact of antiepileptic drugs on children's cognitive development and quality of life by reducing the need for long-term pharmacological treatments.Experts and DiscussionsThe event will host renowned experts, both national and international, who will share their expertise, discuss the latest advancements, and explore future perspectives in pediatric epilepsy surgery.Registration and ProgramRegistrationProgramDate: November 8, 2024Time: 8:30 AM - 5:30 PMLocation: Musée de la Médecine, Erasme Hospital ULB, 808 route de Lennik, 1070 BrusselsContact Information: Email: Symposium_Epilepsy [dot] Neurosurgery [at] hubruxelles [dot] beFees:Medical Professionals: €60Paramedical Professionals and Students: €20
Health issues
Systemic Mastocytosis
What is systemic mastocytosis Systemic mastocytosis is a rare disease. Mastocytosis is a group of diseases that cause an excessive build up of mast cells in the body. A mast cell is a type of white blood cell that helps our immune system to function correctly.  When you suffer from systemic mastocytosis an excess of mast cells builds up in the skin, bone marrow, digestive tract or other body organs. When activated these mast cells release substances that can trigger signs and symptoms similar to those of an allergic reaction. Serious inflammation can sometimes cause organic lesions. Common triggers include alcohol, spicy food, insect bites and some medicines. Mast cell activation syndrome and systemic mastocytosis present the same signs and symptoms. In the case of mast cell activation syndrome there is no build up of mast cells in the bone marrow. Systemic mastocytosis is also characterised by the presence of a mutation of the c-KIT gene. This mutation is not generally hereditary.  Care The signs and symptoms of systemic mastocytosis depend on the part of the body affected by an excess of mast cells. An excess of mast cells can build up in the skin, liver, spleen, bone marrow or intestines. More rarely, other organs such as the brain, heart or lungs can also be affected The signs and symptoms of systemic mastocytosis can include Flushing, itching.Abdominal pain, diarrhoea, nausea or vomiting.Palpitations, feeling faint.Allergic reactions ranging from urticaria to Quincke’s oedema and anaphylaxis Coughing, shortness of breath, rhinorrhea, lachrymation.Frequent urination, urinary burning.Bone and muscle pain.Depression, mood changes or problems concentrating.Anaemia or bleeding disorders.Enlarged liver, spleen or lymph nodes.The various triggers for mastocytosis symptoms include: Insect bites.Food rich in histamine or histamine liberators.Physical factors (change in temperature, fever) Surgery, traumas.Certain medicines.To diagnose systemic mastocytosis a biopsy of the organ or organs affected is necessary to establish the link between the symptoms and the illness. The biopsy is to detect the presence of an accumulation of mast cells as well as the c-KIT mutation. The tryptase level is a blood marker that is very often useful for the diagnosis. Once the diagnosis has been established a number of additional examinations must be carried out (abdominal ultrasound, bone density test, osteo-medular biopsy) to determine the severity.   There are two aspects to mastocytosis treatment. The symptomatic treatment aims to control the symptoms whereas the antiproliferative treatment aims to control the excessive production and accumulation of mast cells in the organs. Antiproliferative treatment is not always required and will depend on the specialist’s assessment. Symptomatic treatment is based on identifying and eliminating factors that trigger the symptoms as well as the use of antihistamines, antacids and other anti-allergy medication. An adrenaline pen is proposed to patients who have had a severe anaphylactic reaction.The antiproliferative treatment is based on chemotherapy and certain targeted therapies. In rare cases an allogeneic stem cell transplant can be envisaged  Advice If you are being monitored for a stystemic mastocytosis and you have respiratory distress or feel faint (Quincke’s oedema or anaphylaxis) you should go immediately to the emergency department or dial 112. If you have an auto-injector EPIPEN (adrenaline) you should use it to make an intramuscular injection while awaiting the arrival of the ambulance.  Focus Patients with symptoms that are suspected to indicate a mastocytosis will be directed to a consultation with a specialist. You may be directed initially to haematology or internal medicine and then redirected to another specialist depending on the results.  Our specialists Related services
Systemic Mastocytosis